EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,430
+20 (0.16%)
At close: Dec 5, 2025

EuBiologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
455,526443,892418,137324,3591,271,414655,399
Market Cap Growth
-24.02%6.16%28.91%-74.49%93.99%-
Enterprise Value
-440,624418,132320,5501,239,111-
Last Close Price
12430.0012150.0011470.008900.0035050.0021300.00
PE Ratio
18.3217.85----
PS Ratio
4.744.626.035.8532.2823.01
PB Ratio
--3.992.7210.846.77
P/TBV Ratio
--3.882.6610.756.87
P/FCF Ratio
--21.43---
P/OCF Ratio
--15.8150.37-395.02
EV/Sales Ratio
-4.596.035.7831.46-
EV/EBITDA Ratio
--24.7977.93--
EV/EBIT Ratio
-12.8454.31---
EV/FCF Ratio
--21.43---
Debt / Equity Ratio
--0.140.130.130.23
Debt / EBITDA Ratio
--0.883.81--
Debt / FCF Ratio
--0.76---
Asset Turnover
--0.440.360.26-
Inventory Turnover
--2.261.952.01-
Quick Ratio
--0.780.591.991.65
Current Ratio
--1.631.673.112.03
Return on Equity (ROE)
---13.70%-2.90%-26.17%-
Return on Assets (ROA)
--3.07%-1.51%-2.95%-
Return on Capital (ROIC)
--3.78%-1.76%-3.58%-
Return on Capital Employed (ROCE)
--6.10%-2.70%-5.40%-4.90%
Earnings Yield
5.46%5.60%-3.32%-0.34%-2.17%-9.18%
FCF Yield
--4.67%-0.81%-1.12%-0.97%
Buyback Yield / Dilution
---0.13%-2.68%-26.53%-
Source: S&P Capital IQ. Standard template. Financial Sources.